XRCC3 Gene Polymorphism Is Associated with Survival in Japanese Lung Cancer Patients

By Osawa Kayo   Nakarai Chiaki   Uchino Kazuya   Yoshimura Masahiro   Tsubota Noriaki   Takahashi Juro   Kido Yoshiaki  

International Journal of Molecular Sciences, Vol. 13, Iss. 12, 2012-12 ,pp. : 16658-16667

MDPI

Access to resources Recommend Favorite

Programmed Death Ligand 1 (PD-L1) Tumor Expression Is Associated with a Better Prognosis and Diabetic Disease in Triple Negative Breast Cancer Patients

By Botti Gerardo   Collina Francesca   Scognamiglio Giosuè   Rao Federica   Peluso Valentina   De Cecio Rossella   Piezzo Michela   Landi Gabriella   De Laurentiis Michelino   Cantile Monica   Di Bonito Maurizio  

International Journal of Molecular Sciences, Vol. 18, Iss. 2, 2017-02 ,pp. : 459-459

MDPI

Access to resources Recommend Favorite

PD‐L1 expression in melanoma shows marked heterogeneity within and between patients: implications for anti‐PD‐1/PD‐L1 clinical trials

By  

PIGMENT CELL & MELANOMA RESEARCH, Vol. 28, Iss. 3, 2015-05 ,pp. : 245-253

John Wiley & Sons Inc

Access to resources Recommend Favorite

Immune Monitoring of Cancer Patients Prior to and During CTLA-4 or PD-1/PD-L1 Inhibitor Treatment

By Tunger Antje   Kießler Maximilian   Wehner Rebekka   Temme Achim   Meier Friedegund   Bachmann Michael   Schmitz Marc  

Biomedicines, Vol. 6, Iss. 1, 2018-03 ,pp. : 26-26

MDPI

Access to resources Recommend Favorite

Modulation of MDR1 and MRP3 Gene Expression in Lung Cancer Cells after Paclitaxel and Carboplatin Exposure

By Melguizo Consolación   Prados Jose   Luque Raquel   Ortiz Raúl   Caba Octavio   Álvarez Pablo J.   Gonzalez Beatriz   Aranega Antonia  

International Journal of Molecular Sciences, Vol. 13, Iss. 12, 2012-12 ,pp. : 16624-16635

MDPI

Access to resources Recommend Favorite